Tishi Shah, MD
Attending Physician, Blood Disorders Center
Instructor in Pediatrics, Harvard Medical School
Image
Tishi Shah, MD
Attending Physician, Blood Disorders Center
Instructor in Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
Government Medical College Surat/Veer Narmad South Gujarat University
Surat, Gujarat
India
Residency
Pediatrics
Saint Peter's University Hospital
New Brunswick
NJ
Fellowship
Pediatric Hematology, Oncology and Stem Cell Transplant
Maria Fareri Children's Hospital at Westchester Medical Center/ New York Medical College
Valhalla
NY
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Hematology-Oncology)
Publications
Cutaneous adverse events associated with MEK-inhibitors for the treatment of vascular anomalies: a dual-center retrospective study. View Abstract
Patient and Caregiver Perspectives on Clinical Care, Comprehensive Support, and Communication in Langerhans Cell Histiocytosis Management. View Abstract
Fetal therapy with mTOR inhibitors in cardiac rhabdomyoma and lymphatic malformations. View Abstract
Practice Variations in Managing Infantile Hemangiomas. View Abstract
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL. View Abstract
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model. View Abstract
Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy. View Abstract